Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Partnership Publications

Joint Partnership Publications = 54

**Faculty Recruitment Publications

***Trainee Publications

***From Partnership Activities

 

1.         Smoot DT, Elliott TB, Verspaget HW, Jones D, Allen CR, Vernon KG, Bremner T, Kidd LC, Kim KS, Groopman JD, and Ashktorab H. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis. 2000;21(11):2091-5. *

2.         Kittles RA, Panguluri RK, Chen W, Massac A, Ahaghotu C, Jackson A, Ukoli F, Adams-Campbell L, Isaacs W, Dunston GM. Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans. Cancer Epidemiol Biomarkers Prev. 2001;10(9):943-7. *

3.         Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, and Dunston GM. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Hum Genet. 2002;110(6):553-60. *

4.         Alberg AJ, Diette GB, Ford JG. Invited commentary: Attendance and absence as markers of health status--the example of active and passive cigarette smoking. Am J Epidemiol. 2003;157(10):870-3. **

5.         Ashktorab H, Smoot DT, Carethers JM, Rahmanian M, Kittles R, Vosganian G, Doura M, Nidhiry E, Naab T, Momen B, Shakhani S, Giardiello FM. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003 Mar;9(3):1112-7. Erratum in: Clin Cancer Res. 2003;9(8):3217. Shakhani, Shahed [corrected to Shakhani, Shahid. *

6.         Ashktorab H, Ahmed A, Littleton G, Wang XW, Allen CR, Tackey R, Walters C, Smoot DT. p53 and p14 increase sensitivity of gastric cells to H. pylori-induced apoptosis. Dig Dis Sci. 2003;48(7):1284-91. 

7.         Hasan S, Hassan M, Oke L, Dinh K, Onojobi G, Lombardo F, Dawkins F, Jack M. Advanced  gastrointestinal stromal tumors successfully treated with imatinib mesylate: a report of two cases. J Natl Med Assoc. 2003;95(12):1208-10. **

8.         Kanaan Y, Kpenu E, Utley K, Adams-Campbell L, Dunston GM, Brody LC, Broome C.   Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer:  a study of familial and early onset cases. Hum Genet. 2003;113(5):452-60. **

9.         Patten CA, Vickers KS, Martin JE, Williams CD. Exercise interventions for smokers with a history of alcoholism: exercise adherence rates and effect of depression on adherence. Addict Behav. 2003;28(4):657-67. **

10.       Taddesse-Heath L, Feldman JI, Fahle GA, Fischer SH, Sorbara L, Raffeld M, Jaffe ES. Florid CD4+, CD56+ T-cell infiltrate associated with Herpes simplex infection simulating nasal NK-/T-cell lymphoma. Mod Pathol. 2003;16(2):166-72. **

11.       Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES. Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol. 2003;27(4):522-31. **

12.       Taylor TR, Kamarck TW, Dianzumba S. Cardiovascular reactivity and left ventricular mass: an integrative review. Ann Behav Med. 2003;26(3):182-93. **

13.       Treiber FA, Kamarck T, Schneiderman N, Sheffield D, Kapuku G, Taylor T. Cardiovascular reactivity  and development of preclinical and clinical disease states. Psychosom Med. 2003;65(1):46-62. **

14.       Baker SD, van Schaik RHN, Rivory LP, Dinh,K, Graveland WJ, Schenk PW, Charles KA, Clarke SJ, Carducci MA, McGuire WP, Dawkins F, Gelderblom H, ten Tije AJ, Verweij J, Sparreboom A  Factors affecting cytochrome P-450 3A activity in cancer patients. Clin. Cancer Res. 2004;10:8341. *

15.       Ford JG and Howerton MW. The science of recruiting minority populations to screening trials. Clinical Trials. 2004;1:341-2. **

16.       Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res. 2004;64(14):4728-35. **

17.       Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer. 2004;11(4):709-24. **

18.       Mason JA, Yancy HF, Lashley K, Jett M, Day AA. Comparative study of matrix metalloproteinase expression between African American and Caucasian Women. J Carcinog. 2004;3(1):15. ****

19.       Makambi KH, The effect of the heterogeneity variance estimator on some tests of treatment efficacy. Journal of Biopharmaceutical Statistics. 2004;14(2):439-449. **`

20.       Makambi KH, On positive estimation of the between-study variance in a one-way random effects anova model. Journal of Satistical Research. 2004;38:33-44. **

21.       Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res. 2004;10(6):2052-7. *

22.       Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W, Kittles RA. COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis. 2004;25(6):961-6. *

23.       Reyes MO, Archer JA, Nunlee-Bland G, Morgan DG, Morgan OA, Makambi K.  Bone mass in physicians:  a Howard University Hospital pilot study.  J Natl Med Assoc. 2004;96:299-305. **

24.       Taylor TR, Kamarck TW, Shiffman S. Validation of the Detroit Area Study Discrimination Scale in a community sample of older African American adults: the Pittsburgh healthy heart project. Int J Behav Med. 2004;11(2):88-94. **

25.       Ashktorab H, Smoot DT, Farzanmehr H, Fidelia-Lambert M, Momen B, Hylind L, Iacosozio-Dononue C, Carethers JM, Goel A, Boland CR, Giardiello FM. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer. 2005;116(6):914-9. *

26.       Copeland RL Jr, Leggett YA, Kanaan YM, Taylor RE, Tizabi Y. Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease. Neurotox Res. 2005;8(3-4):289-93. **

27.       Ford JG, Howerton MW, Bolen S, Gary TL, Lai GY, Tilbert J, Gibbons, MC, Baffi C, Wilson, RF, Feuerstein, CJ, Tanpitukpongse P, Powe NR, Bass EB.  Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report/Technology Assessment (Summ). 2005;122:1-11. **

28.       Garza MA, Luan J, Blinka M, Farabee-Lewis RI, Neuhaus CE, Zabora JR, Ford JG. A culturally targeted intervention to promote breast cancer screening among low-income women in East Baltimore, Maryland. Cancer Control. 2005;12 Suppl 2:34-41. **

29.       Hudson TS, Stoner GD, Morse MA, Young H, Mallery SR. Comparison of phenethyl and 6-phenylhexyl isothiocyanate-induced toxicity in rat esophageal cell lines with and without glutathione depletion. Toxicol Lett. 2005;155(3):427-36. **

30.       Kidd LC, Paltoo DN, Wang S, Chen W, Akereyeni F, Isaacs W, Ahaghotu C, Kittles R. Sequence variation within the 5’ regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. Prostate. 2005;64(3):272-82. *

31.       ten Tije AJ, Verweij J, Carducci MA, Rogers T, Pronk T, Verbruggen MP,  Dawkins F, Baker SD. Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly. J Clin Oncol. 2005;20:1070-7. *

32.       Wambulwa C, Bwayo S, Laiyemo AO, Lombardo F. Trimethoprim-sulfamethoxazole-induced aseptic meningitis. J Natl Med Assoc. 2005;97(12):1725-8. **

33.       Yegnasubramanian S, Lin X, Haffner MC, DeMarzo AM, Nelson WG. Combination of  methylated-DNA precipitation and methylation-sensitive restriction enzymes(COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation. Nucleic Acids Res. 2006;34(3):e19. *

34.       Bolen S, Tilburt J, Baffi C, Gary TL, Powe N, Howerton M, Ford J, Lai G, Wilson R, Bass E. Defining "success" in recruitment of underrepresented poulations to cancer clinical trials: moving toward a more consistent approach.  Cancer. 2006;106(6):1197-204. **

35.       Carter-Nolan PL, Adams-Campbell LL, Makambi K, Lewis S, Palmer JR, Rosenberg L.  Validation of physical activity instruments:  Black Women’s Health Study.  Ethn Dis 16:943-7, 2006. **

36.       Ford JG, McCaffrey L. Understanding disparities in asthma outcomes among African Americans. Clin Chest Med. 2006;27(3):423-30. ** - No. 37 was a duplicate of this.

37.       Natarajan TG, Ganesan N, Carter-Nolan P, Tucker CA, Shields PG, Adams-Campbell  LL gamma-Radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev. 2006;15(3):437-42. 

38.       Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voloshin Y, Von Wyl V, Bacon M, Minkoff H, Levine A, Cohen M, Greenblatt RM. The association of serum ferritin and transferrin receptor concentrations with mortality in HIV-infected women. Haematologica. 2006;91(6):739-43. ***

39.       Gu X, Schwartz JL, Pang X, Zhou Y, Sirois DA, Sridhar R. Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture. Cancer Lett. 2006;239(2):281-91. ***

40.       Hudson TS, Forman MR, Cantwell MM, Schatzkin A, Albert PS, Lanza E. Dietary fiber intake: assessing the degree of agreement between food frequency questionnaires and 4-day food records. J Am Coll Nutr. 2006;25(5):370-81. **

41.       Kamineni P, Baptiste A, Hassan M, Dawkins FW, Zaidi S, Tefferi A, Lindsey M, Taddesse-Heath L. Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C. J Natl Med Assoc. 2006;98(8):1356-60. **

42.       Kidd LR, Coulibaly A, Templeton TM, Chen W, Long LO, Mason T, Bonilla C, Akereyeni F, Freeman V, Isaacs W, Ahaghotu C, Kittles RA. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer. Prostate Cancer Prostatic Dis. 2006;9(3):284-92. *

43.       Lai GY, Gary TL, Tilburt J, Bolen S, Baffi C, Wilson RF, Howerton MW, Gibbons MC, Tanpitukpongse TP, Powe NR, Bass EB, Ford JG. Effectiveness of strategies to  recruit underrepresented populations into cancer clinical trials. Clin Trials. 2006;3(2):133-41. **

44.       Poultsides GA, Frederick WA. Carcinoid of the ampulla of Vater: morphologic features and clinical implications. World J Gastroenterol. 2006;12(43):7058-60. **

45.       Rosenberg L, Boggs D, Wise LA, Palmer JR, Roltsch MH, Makambi KH, Adams-Campbell LL.  A follow-up study of physical activity and incidence of colorectal polyps in African-American women.  Cancer Epidemiol Biomarkers Prev. 2006;15:1438-42. **

46.       Visvanathan K, Santor D, Ali SZ, Hong IS, Davidson NE, Helzlsouer KJ. The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2553-6. *

47.       Wang J, Thompson B, Ren C, Ittmann M, Kwabi-Addo B. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. Prostate. 2006;66(6):613-24. **

48.       Adams-Campbell LL, Makambi KH, Palmer JR, Rosenberg L.  Diagnostic Accuracy of the Gail model in the Black Women’s Health Study.  Breast J. 2007;13:332-6. **

49.       Ashktorab H, Begum R, Akhgar A, Smoot DT, Elbedawi M, Daremipouran M, Zhao A, Momen B, Giardiello FM. Folate status and risk of colorectal polyps in African Americans. Dig Dis Sci. 2007;52(6):1462-70. *

50.       Copeland RL Jr, Das JR, Bakare O, Enwerem NM, Berhe S, Hillaire K, White D, Beyene D, Kassim OO, Kanaan YM. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines. Anticancer Res. 2007;27(3B):1537-46. **

51.       Copeland RL Jr, Das JR, Kanaan YM, Taylor RE, Tizabi Y. Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res. 2007;12(1):61-9. **

52.       Das J., Williams D., and Hill-Williams K. Phosphatidylinositol 3-kinase Class IA p110β isoform is the predominate expressed isoform  in prostate cancer cell lines and is the major Class IA PI 3-kinase contributor to prostate cancer cell survival.  American Association for Cancer Research, 2007. **

53.       Howerton MW, Gibbons MC, Baffi CR, Gary TL, Lai GY, Bolen S, Tilburt J, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB, Ford JG. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer. 2007;109(3):465-76. **

54.       Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res. 2007;67(17):8396-405. **

55.       Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome. Ann Surg Oncol. 2007;14(10):2994-3003. **

56.       Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, Issa JP. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res. 2007;13(13):3796-802. **

57.       Paskett ED, Reeves KW, Rohan TE, Allison MA, Williams CD, Messina CR, Whitlock E, Sato A, Hunt JR. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst. 2007;99(22):1729-35. **

58.       Shan L, Wang S, Sridhar R, Bhujwalla ZM, Wang PC. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts. Mol Imaging. 2007;6(2):85-95. **

59. Smith KC, Stillman F, Bone L, Yancey N, Price E, Belin P, Kromm EE. Buying and selling "loosies" in Baltimore: the informal exchange of cigarettes in the community context. J Urban Health. 2007;84(4):494-507. ****

60.       Stillman FA, Bone L, Avila-Tang E, Smith K, Yancey N, Street C, Owings K. Am J Public Health. 2007;97(8):1405-8. ****

61.       Taylor TR, Williams CD, Makambi KH, Mouton C, Harrell JP, Cozier Y, Palmer JR, Rosenberg L, Adams- Campbell LL. Racial discrimination and breast cancer incidence in US Black women: the Black Women's Health Study. Am J Epidemiol. 2007;166(1):46-54. **

62.       Tilburt J, Ford JG, Howerton MW, Gary TL, Lai GY, Bolen SB, Baffi C, Wilson RF, Tanpitukpongse TP, Powe NR, Bass EB, Sugarman J. Applying Justice in Clinical Trials for Underrepresented Populations. Clin Trials. 2007;4:264-9. **

63.       Tudson, T. AACR Science of Cancer Health Disparity Conference: Phenethyl isothiocyanate inhibits the growth of androgen-dependent transplantable human prostate tumors that correlates with a decrease in CD31 a marker of tumor angiogenesis. 2007. **

64.       Williams CD, Taylor TR, Makambi K, Harrell J, Palmer JR, Rosenberg L, Adams-Campbell LL. CES-D four-factor structure is confirmed, but not invariant, in a large cohort of African American women. Psychiatry Res. 2007;150(2):173-80. **

65.       Yancy HF, Mason JA, Peters S, Thompson CE 3rd, Littleton GK, Jett M, Day AA. Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women. J Carcinog. 2007;6:8. ****

66.       Aggarwal A, Freund K, Sato A, Adams-Campbell LL, Lopez AM, Lessin LS, Ockene  J, Wallace RB, Williams CD, Bonds DE. Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women's Health Initiative observational cohort. J Womens Health (Larchmt). 2008;17(8):1353-61. PMCID: PMC2944436. **

67.       Bloch EF, Morrison K, McDonald-Pinkett S, Baskin S, Campbell S, Peters S, Dillahunt S, Evans D, Lucas S, Macatangay A, Kanaan Y. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin. Immunol Invest. 2008;37(3):245-61. **

68.       Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, Al-Mjeni R, Al-Sayegh A, Raeburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H. Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer. 2008;7:68. PMCID: PMC2551625. *

69.       Chung W, Kwabi-Addo B, Ittmann M, Jelinek J, Shen L, Yu Y, Issa JP Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. PLoS ONE . 2008;3(4): e2079. PMCID: PMC2323612. **

70.       Evans J, Kozol R, Frederick W, Voytavich A, Pennoyer W, Lukianoff A, Lardner  J. Does a 48-hour rule predict outcomes in patients with acute sigmoid diverticulitis? J Gastrointest Surg. 2008;12(3):577-82. Erratum in: J Gastrointest Surg. 2008;12(7):1307. Kozol, Robert [added]; Frederick, Wayne [added]; Voytavich, Anthony [added]; Pennoyer, William [added];  Lukianoff, Alexandra [added]; Lardner, Jennifer [added]. (Not Supported Through NIH Funding). **

71.       Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112(2):228-42. (Not Supported Through NIH Funding). **

72.       Gordeuk VR, Diaz SF, Onojobi GO, Kasvosve I, Debebe Z, Edossa A, Pantin JM, Xiong S, Nekhai S, Nouraie M, Tsukamoto H, Taylor RE. Ferroportin Q248h, dietary  iron, and serum ferritin in community African-Americans with low to high alcohol consumption. Alcohol Clin Exp Res. 2008;32(11):1947-53. PMCID: PMC3369540. **

73.       Gu X, Song X, Dong Y, Cai H, Walters E, Zhang R, Pang X, Xie T, Guo Y, Sridhar R, Califano JA. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res. 2008;14(6):1840-8. (Prior to April 2008). *

74.       Hill-Williams K, Johnson WD, Das J, Marshal VJ, Ferguson CL, Taylor RE.  Alcohol promotes a time dependent modulation in activation of crucial signaling proteins AKT and ERK1/2 involved in prostate cancer cells survival.  Alcoholism: Clinical and Experimental Research, 2008. **

75.       Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD Jr, Dewitty RL Jr, Frederick WA. Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women. Am J Surg. 2008;195(2):153-8. (Not Supported Through NIH Funding). **

76.       Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD Jr, DeWitty RL Jr, Frederick WA. Treatment and survival outcome for molecular breast cancer subtypes in black women. Ann Surg. 2008;247(3):463-9. (Prior to April 2008). **

77.       Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet. 2008;40(6):741-50. Epub 2008 May 18. PubMed PMID: 18488029. **

78.       Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z, Cross AJ, Marcus PM, Caan B, Marshall JR, Lance P, Paskett ED, Weissfeld J, Slattery ML, Burt R, Iber  F, Shike M, Kikendall JW, Lanza E, Schatzkin A. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med. 2008;148(6):419-26. (Prior to April 2008). **

79.       Laiyemo AO, Smoot DT. Metastatic gastric stump cancer occurring six years after a partial gastrectomy for gastric ulcer. J Natl Med Assoc. 2008;100(6):737-9. (Not Supported Through NIH Funding). **

80.       Murphy G, Sansbury LB, Cross AJ, Stolzenberg-Solomon R, Laiyemo A, Albert PS, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control.  2008;19(7):751-8. PubMed PMID: 18322814. **

81.       Nathan H, Frederick W, Choti MA, Schulick RD, Pawlik TM. Racial disparity in surgical mortality after major hepatectomy. J Am Coll Surg. 2008;207(3):312-9. Erratum in: J Am Coll Surg. 2010;211(2):301. PubMed PMID: 18722934. *

82.       Scott DM, Williams CD, Cain GE, Kwagyan J, Kalu N, Ehlers CL, Hesselbrock V,  Taylor RE. Clinical course of alcohol dependence in African Americans. J Addict Dis. 2008;27(4):43-50. PubMed PMID: 19042590. **

83.       Shan L, Hao Y, Wang S, Korotcov A, Zhang R, Wang T, Califano J, Gu X, Sridhar R, Bhujwalla ZM, Wang PC. Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate. Mol Imaging. 2008;7(1):42-9. (Prior to April 2008). *

84.       Singh P, Hallur G, Anchoori RK, Bakare O, Kageyama Y, Khan SR, Isaacs JT. Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate. 2008;68(14):1570-81. PMCID: PMC3087493. *

85.       Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN, Hursting SD. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis. 2008;29(10):2001-10. PMCID: PMC2722852. **

86.       Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry  RA, Morgan J, Hicks J, DeWeese TL, Isaacs WB, Bova GS, DeMarzo AM, Nelson WG. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 2008;68(21):8954-67. PMCID: PMC2577392. **

87.       Adams-Campbell LL, Makambi KH, Frederick WA, Gaskins M, Dewitty RL, McCaskill-Stevens W. Breast cancer risk assessments comparing Gail and CARE models in African-American women. Breast J. 2009;15 Suppl 1:S72-5. PubMed PMID: 19775333. **

88.       Agurs-Collins T, Rosenberg L, Makambi K, Palmer JR, Adams-Campbell L. Dietary patterns and breast cancer risk in women participating in the Black Women's Health Study. Am J Clin Nutr. 2009;90(3):621-8. PMCID: PMC2728646. **

89.       Brait M, Ford JG, Papaiahgari S, Garza MA, Lee JI, Loyo M, Maldonado L, Begum  S, McCaffrey L, Howerton M, Sidransky D, Emerson MR, Ahmed S, Williams CD, Hoque  MO. Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2984-91. PMCID: PMC2878974. *

90.       Chang CL, Ma B, Pang X, Wu TC, Hung CF. Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer. Mol Ther. 2009;17(8):1365-72. PMCID: PMC2835247. *

91.       Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2170-5. PMCID: PMC3018698. **

92.       Hao Y, Xie T, Korotcov A, Zhou Y, Pang X, Shan L, Ji H, Sridhar R, Wang P, Califano J, Gu X. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int J Cancer. 2009;124(9):2200-9. PMCID: PMC2849633. *

93.       Ihemelandu CU, DeWitty RL Jr, Leffall LD Jr, Suryanarayana MS, Frederick WA. Trends in clinicopathologic characteristics and prognostic predictors of survival outcome in black patients with gastric carcinoma: a single institution's experience. J Surg Res. 2009t;156(2):325-32. (Not Supported Through NIH Funding). **

94.       Ihemelandu CU, Dewitty RL Jr, Leffall LD Jr, Suryanarayana SM, Frederick WA. Clinical significance of p53 and bcl-2 protein coexpression phenotypes in molecular breast cancer subtypes of pre-menopausal and post-menopausal African-American women. Am Surg. 2009;75(9):776-84; discussion 784. (Not Supported Through NIH Funding). **

95.       Kanaan YM, Das JR, Bakare O, Enwerem NM, Berhe S, Beyene D, Williams V, Zhou Y, Copeland RL Jr. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.  Anticancer Res. 2009;29(1):191-9. NIHMS434388. **

96.       Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL, Ashktorab H. Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res. 2009;15(4):1155-61. PMCID: PMC2713502. *

97.       Kwabi-Addo B, Ren C, Ittmann M. DNA methylation and aberrant expression of Sprouty1 in human prostate cancer. Epigenetics. 2009;4(1):54-61. PubMed PMID: 19164898. **

98.       Laiyemo AO, Jack M, Dawkins FW, Smoot DT. Upper gastrointestinal bleeding from metastatic testicular cancer. J Natl Med Assoc. 2009;101(8):808-9. (Not Supported Through NIH Funding). **

99.       Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study. Cancer Epidemiol. 2009;33(5):368-73. PMCID: PMC2787955. **

100.     Laiyemo AO, Murphy G, Sansbury LB, Wang Z, Albert PS, Marcus PM, Schoen RE, Cross AJ, Schatzkin A, Lanza E. Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7(2):192-7. PMCID: PMC3498978. **

101.     Laiyemo AO, Pinsky PF, Marcus PM, Lanza E, Cross AJ, Schatzkin A, Schoen RE.  Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7(5):562-7; quiz 497. PMCID: PMC2701893. **

102.     Makambi KH, Williams CD, Taylor TR, Rosenberg L, Adams-Campbell LL. An assessment of the CES-D scale factor structure in black women: The Black Women's  Health Study. Psychiatry Res. 2009;168(2):163-70. PMCID: PMC2704501. **

103.     Nelson WG, DeMarzo AM, Yegnasubramanian S. Epigenetic alterations in human prostate cancers. Endocrinology. 2009;150(9):3991-4002. PMCID: PMC2736081. **

104.     Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu  B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E. Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial. Int J Cancer. 2009;124(9):2148-51. PMCID: PMC2768275. **

105.     Pollack CE, Armstrong K. The geographic accessibility of retail clinics for underserved populations. Arch Intern Med. 2009;169(10):945-9; discussion 950-3. (Not Supported Through NIH Funding). **

106.     Pollack CE, Lynch J. Health status of people undergoing foreclosure in the Philadelphia region. Am J Public Health. 2009;99(10):1833-9. PMCID: PMC2741520. **

107.     Putt M, Long JA, Montagnet C, Silber JH, Chang VW, Kaijun Liao, Schwartz JS, Pollack CE, Wong YN, Armstrong K. Racial differences in the impact of comorbidities on survival among elderly men with prostate cancer. Med Care Res Rev. 2009;66(4):409-35. PMCID: PMC2780425. **

108.     Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Agurs-Collins T, Platz EA. Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male  neonates. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1484-91. PMCID: PMC3012385. *

109.     Rudavsky R, Pollack CE, Mehrotra A. The geographic distribution, ownership, prices, and scope of practice at retail clinics. Ann Intern Med. 2009;151(5):315-20. PMCID: PMC2746672. **

110.     Smith KC, Bone L, Clay EA, Owings K, Thames S, Stillman F. Partnering with education and job and training programs for sustainable tobacco control among Baltimore african american young adults. Prog Community Health Partnersh. 2009;3(1):3-4. (Not Supported Through NIH Funding). ****

111.     Wang PC, Blumenthal RP, Zhao YL, Schneider JA, Miller N, Grodzinski P, Gottesman MM, Tinkle S, Wang K, Wang C, Liang XJ.  Building Scientific Progrss Without Borders: Nanobiology and Nanomedicine in China and the U.S. Cancer Res 2009;69:(13)5294-5295. PMCID: PMC2756036. *

112.     Yu W, Kanaan Y, Bae YK, Gabrielson E. Chromosomal Changes in Aggressive Breast Cancers with Basal-Like Features. Cancer Genet Cytogenet. 2009;193(1):29-37. PMCID: PMC2768045. *

113.     Adams-Campbell LL, Makambi K, Mouton CP, Palmer JR, Rosenberg L. Colonoscopy utilization in the Black Women's Health Study. J Natl Med Assoc. 2010;102(3):237-42. PMCID: PMC2895509. **

114.     Bobe G, Murphy G, Rogers CJ, Hance KW, Albert PS, Laiyemo AO, Sansbury LB, Lanza E, Schatzkin A, Cross AJ. Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1441-52. PMCID: PMC2882997. **

115.     Chen H, Liu W, Roberts W, Hooker S, Fedor H, DeMarzo A, Isaacs W, Kittles RA. 8q24 allelic imbalance and MYC gene copy number in primary prostate cancer. Prostate Cancer Prostatic Dis. 2010;13(3):238-43. Epub 2010 Jul 13. (Not Supported Through NIH Funding). * 116.  DeMarzo AM, Nelson WG, Bieberich CJ, Yegnasubramanian S. Prostate cancer: New answers prompt new questions regarding cell of origin. Nat Rev Urol. 2010;7(12):650-2. (Not Supported Through NIH Funding). **

117.     Doubeni CA, Laiyemo AO, Klabunde CN, Young AC, Field TS, Fletcher RH. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med. 2010;38(2):184-91. PMCID: PMC2827335. **

118.     Doubeni CA, Laiyemo AO, Young AC, Klabunde CN, Reed G, Field TS, Fletcher RH. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med. 2010;8(4):299-307. PMCID: PMC2906524. **

119.     Downing S, Ahuja N, Oyetunji TA, Chang D, Frederick WA. Disparity in limb-salvage surgery among sarcoma patients. Am J Surg. 2010;199(4):549-53. (Not Supported Through NIH Funding). *

120.     Downing SR, Cadogan KA, Ortega G, Jaji Z, Bolorunduro OB, Oyetunji TA, Chang  DC, Ford DH, Frederick WA. The number of lymph nodes examined debate in colon cancer: how much is enough? J Surg Res. 2010;163(2):264-9. Epub 2010 Apr 1. (Not Supported Through NIH Funding). **

121.     Frederick WA, Ames S, Downing SR, Oyetunji TA, Chang DC, Leffall LD Jr. Surgical treatment for women with breast cancer: do randomized clinical trials represent current medical practices? Am Surg. 2010;76(6):630-6. (Not Supported Through NIH Funding). **

122.     Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, Isaacs WB, Bova GS, Liu W, Xu J, Meeker AK, Netto G, DeMarzo AM, Nelson WG, Yegnasubramanian S. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet. 2010;42(8):668-75. PMCID: PMC3157086. **

123.     Kanaan YM, White DF, Das JR, Berhe S, Bakare O, Kenguele H, Beyene D, Zhou Y, Day AA, Copeland RL Jr. Cytotoxic effects of N-(3-chloro-1,4-dioxo 1,4-dihydro-naphthalen-2-yl)-benzamide on androgen-dependent and –independent prostate cancer cell lines. Anticancer Res. 2010;30(2):519-27. NIHMS434391. **

124.     Klamerus JF, Bruinooge SS, Ye X, Klamerus ML, Damron D, Lansey D, Lowery JC, Diaz LA Jr, Ford JG, Kanarek N, Rudin CM. The impact of insurance on access to cancer clinical trials at a comprehensive cancer center. Clin Cancer Res. 2010;16(24):5997-6003. (Not Supported Through NIH Funding). *

125.     Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin Cancer Res. 2010;16(14):3539-47. Epub 2010 Jul 6. PubMed PMID: 20606036. **

126.     Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, Crawford ED, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus  PM, Prorok PC, Berg CD. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010;102(8):538-46. PMCID:  PMC2857802. **

127.     Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control. 2010;21(1):163-70. Epub 2009 Oct 17. PMCID: PMC3510266. **

128.     Leung K, Pinsky P, Laiyemo AO, Lanza E, Schatzkin A, Schoen RE. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc. 2010;71(1):111-7. Epub  2009 Jul 31. PMCID: PMC3501210. **

129.     Liang XJ, Chen C, Zhao YL, Wang PC.  Circumventing Tumor Resistance to Chemotherapy by Nanotechnology.  Multi-Drug Resistance in Cancer, J. Zhou (ed). Methods in Molecular Biology. 2010;596:467-488. PMCID: PMC3047496. *

130.     McCleary-Sills JD, Villanti A, Rosario E, Bone L, Stillman F. Influences on tobacco use among urban Hispanic young adults in Baltimore: findings from a qualitative study. Prog Community Health Partnersh. 2010;4(4):289-97. PMCID: PMC3087202. ****

131.     Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C, Kittles R,  Bonney G, Dunston GM. Association of CD14 variant with prostate cancer in African American men. Prostate. 2010;70(3):262-9. PMCID: PMC3046920. **

132.     Mouton CP, Carter-Nolan PL, Makambi KH, Taylor TR, Palmer JR, Rosenberg L, Adams-Campbell LL. Impact of perceived racial discrimination on health screening in black women. J Health Care Poor Underserved. 2010;21(1):287-300. PubMed PMID: 20173270. **

133.     Nadler EP, Nwomeh BC, Frederick WA, Hassoun HT, Kingham TP, Krishnaswami S, London JA, Pitt SC, Riviello R, Rogers SO; Global Affairs Committee of the Association for Academic Surgery. Academic needs in developing countries: a survey of the West African College of Surgeons. J Surg Res. 2010;160(1):14-7. (Not Supported Through NIH Funding). **

134.     Philbin, Williams, Bone, Ross, Byron, Stillman. Necessary but not Sufficient: The Influence of Tobacco Control Policies on Urban African American Young Adults. BMC Public Health, June:2010. *

135.     Pollack CE, Gidengil C, Mehrotra A. The growth of retail clinics and the medical home: two trends in concert or in conflict? Health Aff (Millwood). 2010;29(5):998-1003. PMCID: PMC3303880. **

136.     Pollack CE, Griffin BA, Lynch J. Housing affordability and health among homeowners and renters. Am J Prev Med. 2010;39(6):515-21. (Not Supported Through NIH Funding). **

137.     Pollack CE, Lynch J, Alley DE, Cannuscio C. Foreclosure and health status. LDI Issue Brief. 2010;15(2):1-4. (Not Supported Through NIH Funding). **

138.     C. Sears, H. Ashktorab & H. Brim. Do the colonic microbial flora serve to trigger colon cancer? AGA Perspectives. 2010. *

139.     Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, McLauchlin A, Josey D, Bonney G, Dunston GM.  p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate. 2010;70(16):1739-45. PMCID: PMC3057117.***

140.     Siram S, Oyetunji T, Johnson SM, Khoury AL, White PM, Chang DC, Greene WR, Frederick WA. Predictors for survival of penetrating trauma using emergency department thoracotomy in an urban trauma center: the Cardiac Instability Score.  J Natl Med Assoc. 2010 Feb;102(2):126-30. (Not Supported Through NIH Funding). **

141.     Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol. 2010;23(7):991-9. Epub 2010 Mar 26. PubMed PMID: 20348882. **

142.     Ufearo H, Kambal K, Onojobi GO, Nouraie M, Agbemabiese C, Diaz S, Aggarwal A, Aliyu Z, Taylor RE, Gordeuk VR. Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity. Clin Chim Acta. 2010;411(9-10):653-6. PMCID: PMC2847047. **

143.     Valera A, Balagué O, Colomo L, Martínez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E. IG/MYC  rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010 Nov;34(11):1686-94. PubMed PMID:  20962620; PubMed Central PMCID: PMC2982261. **

144.     Wu CY, Monie A, Pang X, Hung CF, Wu TC. Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation. J Biomed Sci. 2010 Nov 22;17:88. PubMed PMID: 21092195; PubMed Central PMCID: PMC3000388. *

145.     Yu W, Kanaan Y, Bae YK, Gabrielson E. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet Cytogenet. 2009;193(1):29-37.  Erratum in: Cancer Genet Cytogenet. 2010;198(1):77. Baed, Young-Kyung [corrected to Bae, Young Kyung]. PMCID: PMC2768045. *

146.     Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev Res (Phila). 2010;3(6):787-96. PMCID: PMC2881190. *

147.     Alley DE, Lloyd J, Pagán JA, Pollack CE, Shardell M, Cannuscio C. Mortgage delinquency and changes in access to health resources and depressive symptoms in  a nationally representative cohort of Americans older than 50 years. Am J Public Health. 2011;101(12):2293-8. PMCID: PMC3222434. *

148.     Ashktorab H, Nouri Z, Nouraie M, Razjouyan H, Lee EE, Dowlati E, El-Seyed el-W, Laiyemo A, Brim H, Smoot DT. Esophageal carcinoma in African Americans: a five-decade experience. Dig Dis Sci. 2011;56(12):3577-82. PMCID: PMC3345949. *

149.     Brandy Y, Ononiwu I, Adedeji D, Williams V, Mouamba C, Kanaan Y, Copeland RL Jr, Wright DA, Butcher RJ, Denmeade SR, Bakare O. Synthesis and cytotoxic activities of some 2-Arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines. Invest New Drugs. 2012;30(4):1709-14. Epub 2011 Jan 18. NIHMS434393. *

150.     Bright-Gbebry M, Makambi KH, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LL. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study. BMC Complement Altern Med. 2011;11:30. PMCID: PMC3095573. *

151.     Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, Stanford JL, Thibodeau SN, Witte JS, Isaacs WB. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res. 2011;71(10):3442-6. PMCID: PMC3096727. *

152.     Cavalli LR, Noone AM, Makambi KH, Rone JD, Kasid UN, Haddad BR. Frequent loss of the BLID gene in early-onset breast cancer. Cytogenet Genome Res. 2011;135(1):19-24. doi: 10.1159/000330265. PMCID: PMC3214676. *

153.     Cubbin C, Pollack C, Flaherty B, Hayward M, Sania A, Vallone D, Braveman P. Assessing alternative measures of wealth in health research. Am J Public Health.  2011;101(5):939-47. Epub 2011 Jan 20. PubMed PMID: 21252050. **

154.     Darimipourain M, Wang S, Ittmann M, Kwabi-Addo B. Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer. Prostate Cancer Prostatic Dis. 2011 Dec;14(4):279-85. doi: 10.1038/pcan.2011.33. Epub 2011 Aug 9. PubMed PMID: 21826097. **

155.     Diehl KM, Green EM, Weinberg A, Frederick WA, Holmes DR, Green B, Morris A, Kuerer HM, Beltran RA, Mendez J, Gines V, Ota DM, Nelson H, Newman LA. Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group. Ann Surg Oncol. 2011;18(13):3544-50. (Not Supported Through NIH Funding). **

156.     Downing S, Akinrinlola A, Siram SM, DeWitty RL Jr, Paul H, Dawson K, Frederick WA. T4b breast masses: a retrospective review of 12 cases presenting to a metropolitan tertiary care center. J Natl Med Assoc. 2011;103(8):757-61. (Not Supported Through NIH Funding). **

157.     Downing SR, Cadogan KA, Ortega G, Oyetunji TA, Siram SM, Chang DC, Ahuja N, Leffall LD Jr, Frederick WA. Early-stage gallbladder cancer in the Surveillance. Epidemiology, and End Results database: effect of extended surgical resection. Arch Surg. 2011;146(6):734-8. (Not Supported Through NIH Funding). *

158.     Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, Toubaji A, Argani P, Iacobuzio-Donahue C, Nelson WG, Netto GJ, DeMarzo AM, Yegnasubramanian S. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2011;2(8):627-37. PMCID: PMC3248214. *

159.     Haffner MC, DeMarzo AM, Meeker AK, Nelson WG, Yegnasubramanian S. Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target? Clin Cancer Res. 2011;17(12):3858-64. PMCID: PMC3117909. *

160.     Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC, Pang X. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila). 2011;4(7):1073-83. PMCID: PMC3305792. *

161.     Hao Y, Zhao Y, Zhao X, He C, Pang X, Wu TC, Califano JA, Gu X. Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling. Cancer Invest. 2011;29(4):318-24. PMCID: PMC3305797. *

162.     Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Chanock SJ, Kolb S, Signorello LB, Yamamura Y, Neslund-Dudas C, Thun MJ, Murphy A, Casey G, Sheng X,  Wan P, Pooler LC, Monroe KR, Waters KM, Le Marchand L, Kolonel LN, Stram DO, Henderson BE. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet. 2011;7(5):e1001387. PMCID: PMC3102736. *

163.     Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, Zeigler-Johnson C, Yamamura Y, Neslund-Dudas C, Haslag-Minoff J, Wu W, Thomas V, Allen GO, Murphy A, Chang BL, Zheng SL, Leske MC, Wu SY, Ray AM, Hennis AJ, Thun  MJ, Carpten J, Casey G, Carter EN, Duarte ER, Xia LY, Sheng X, Wan P, Pooler LC,  Cheng I, Monroe KR, Schumacher F, Le Marchand L, Kolonel LN, Chanock SJ, Van Den Berg D, Stram DO, Henderson BE. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 2011;43(6):570-3. PMCID: PMC3102788. *

164.     Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC, Pang X. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila). 2011;4(7):1073-83. PMCID: PMC3305792. *

165.     Hao Y, Zhao Y, Zhao X, He C, Pang X, Wu TC, Califano JA, Gu X. Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling. Cancer Invest. 2011;29(4):318-24. PMCID: PMC3305797.

166.     Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang  K, Buxbaum SG, Akylbekova EL, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, Bernstein L, Blot WJ, Bock CH, Boerwinkle E, Cai Q, Caporaso N, Casey  G, Cupples LA, Deming SL, Diver WR, Divers J, Fornage M, Gillanders EM, Glessner  J, Harris CC, Hu JJ, Ingles SA, Isaacs W, John EM, Kao WH, Keating B, Kittles RA, Kolonel LN, Larkin E, Le Marchand L, McNeill LH, Millikan RC, Murphy A, Musani S, Neslund-Dudas C, Nyante S, Papanicolaou GJ, Press MF, Psaty BM, Reiner AP, Rich SS, Rodriguez-Gil JL, Rotter JI, Rybicki BA, Schwartz AG, Signorello LB, Spitz M, Strom SS, Thun MJ, Tucker MA, Wang Z, Wiencke JK, Witte JS, Wrensch M, Wu X, Yamamura Y, Zanetti KA, Zheng W, Ziegler RG, Zhu X, Redline S, Hirschhorn JN, Henderson BE, Taylor HA Jr, Price AL, Hakonarson H, Chanock SJ, Haiman CA, Wilson JG, Reich D, Myers SR. The landscape of recombination in African Americans. Nature. 2011;476(7359):170-5. PMCID: PMC3154982. *

167.     Kang TH, Monie A, Wu LS, Pang X, Hung CF, Wu TC. Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection. Vaccine. 2011;29(5):1082-9. PMCID: PMC3026065. *

168.     Laiyemo AO, Doubeni C, Sanderson AK 2nd, Pinsky PF, Badurdeen DS, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Schatzkin A, Cross AJ. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc. 2011;74(2):253-61. PMCID: PMC3148340. **

169.     Laiyemo AO. In search of a perfect solution to ensure that "no colon is left behind". Dig Dis Sci. 2012;57(2):263-5. (Not Supported Through NIH Funding). **

170.     Lian M, Schootman M, Doubeni CA, Park Y, Major JM, Stone RA, Laiyemo AO, Hollenbeck AR, Graubard BI, Schatzkin A. Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP Diet and Health Study Cohort. Am J Epidemiol. 2011;174(7):828-38. PMCID: PMC3203377. **

171.     Miller WD, Pollack CE, Williams DR. Healthy homes and communities: putting the pieces together. Am J Prev Med. 2011;40(1 Suppl 1):S48-57. (Not Supported Through NIH Funding). **

172.     Makambi KH, Agurs-Collins T, Bright-Gbebry M, Rosenberg L, Palmer JR, Adams-Campbell LL. Dietary patterns and the risk of colorectal adenomas: the Black Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2011;20(5):818-25. PMCID: PMC3089689. **

173.     Mao CP, He L, Tsai YC, Peng S, Kang TH, Pang X, Monie A, Hung CF, Wu TC. In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination. Cell Biosci. 2011;1(1):3. PMCID: PMC3116247. *

174.     Nelson WG, Haffner MC, Yegnasubramanian S. Beefing up prostate cancer therapy with performance-enhancing (anti-) steroids. Cancer Cell. 2011;20(1):7-9.  (Not Supported Through NIH Funding). **

175.     Peng S, Monie A, Pang X, Hung CF, Wu TC. Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines. J Biomed Sci. 2011;18:21. PMCID: PMC3062584. *

176.     Pollack CE, Armstrong K. Accountable care organizations and health care disparities. JAMA. 2011;305(16):1706-7. PubMed PMID: 21521853. **

177.     Pollack CE, Bekelman JE, Epstein AJ, Liao K, Wong YN, Armstrong K. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care. 2011;49(11):999-1006. PMCID: PMC3298812. **

178.     Pollack CE, Bekelman JE, Liao KJ, Armstrong K. Hospital racial composition and the treatment of localized prostate cancer. Cancer. 2011;117(24):5569-78.  PubMed PMID: 21692067. **

179.     Pollack CE, Kurd SK, Livshits A, Weiner M, Lynch J. A case-control study of home foreclosure, health conditions, and health care utilization. J Urban Health. 2011;88(3):469-78. PMCID: PMC3126934. **

180.     Ricks-Santi LJ, Sucheston LE, Yang Y, Freudenheim JL, Isaacs CJ, Schwartz MD,  Dumitrescu RG, Marian , Nie J, Vito D, Edge SB, Shields PG. Association of Rad51 polymorphism with DNA repair in BRCA1  mutation carriers and sporadic breast cancer risk. BMC Cancer. 2011;11:278. PMCID: PMC3146938. **

181.     Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol. 2011;106(7):1340-50. PMCID: PMC3183504. **

182.     Seetahal SA, Bolorunduro OB, Sookdeo TC, Oyetunji TA, Greene WR, Frederick W. Cornwell EE 3rd, Chang DC, Siram SM. Negative appendectomy: a 10-year review of a nationally representative sample. Am J Surg. 2011;201(4):433-7. (Not Supported Through NIH Funding). **

183.     Sheppard VB, Makambi K, Taylor T, Wallington SF, Sween J, Adams-Campbell L. Physical activity reduces breast cancer risk in African American women. Ethn Dis. 2011;21(4):406-11. PubMed PMID: 22428342. **

184. Klamerus JF, Bruinooge SS, Ye X, Klamerus ML, Damron D, Lansey D, Lowery JC, Diaz LA Jr, Ford JG, Kanarek N, Rudin CM. The impact of insurance on access to cancer clinical trials at a comprehensive cancer center.  Clin Cancer Res. 2010 Dec 15;16(24):5997-6003. doi: 10.1158/1078-0432.CCR-10-1451. ****

185.     Soldin OP, Makambi KH, Soldin SJ, O'Mara DM. Steroid hormone levels associated with passive and active smoking. Steroids. 2011;76(7):653-9. PubMed PMID: 21396948. **

186.     Taylor TR, Huntley ED, Makambi K, Sween J, Adams-Campbell LL, Frederick W, Mellman TA. Understanding sleep disturbances in African-American breast cancer survivors: a pilot study.  Psychooncology. 2011;doi: 10.1002/pon.2000. (Not Supported Through NIH Funding). **

187.     Taylor TR, Makambi K, Sween J, Roltsch M, Adams-Campbell LL. The effect of a supervised exercise trial on exercise adherence among African American Men: a pilot study. J Natl Med Assoc. 2011;103(6):488-91. (Not Supported Through NIH Funding). **

188.     Vaughn MP, Biswal Shinohara D, Castagna N, Hicks JL, Netto G, DeMarzo AM, Speed TJ, Reichert ZR, Kwabi-Addo B, Henderson CJ, Wolf CR, Yegnasubramanian S, Nelson WG. Humanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdose. PLoS One. 2011;6(10):e25707. PMCID: PMC3191143. *

189.     Wilson-Frederick SM, Williams CD, Garza MA, Navas-Acien A, Emerson MR, Ahmed  S, Ford JG. Association of secondhand smoke exposure with nicotine dependence among Black smokers. Addict Behav. 2011;36(4):412-5. PubMed PMID: 21239118. *

190.     Yegnasubramanian S, Wu Z, Haffner MC, Esopi D, Aryee MJ, Badrinath R, He TL, Morgan JD, Carvalho B, Zheng Q, DeMarzo AM, Irizarry RA, Nelson WG.  Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences. BMC Genomics. 2011;12:313. PMCID: PMC3124442. **

191.     Zeng Q, Peng S, Monie A, Yang M, Pang X, Hung CF, Wu TC. Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents. Hum Gene Ther. 2011;22(7):809-19. PMCID: PMC3135274. *

192.     Zhou X, Meeker AK, Makambi KH, Kosti O, Kallakury BV, Sidawy MK, Loffredo CA, Zheng YL. Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence. Carcinogenesis. 2012;33(1):113-8. PMCID: PMC3276329. **

193.     Aguado Loi CX, Taylor TR, McMillan S, Gross-King M, Xu P, Shoss MK, Huegel V.  Use and helpfulness 0f self-administered stress management therapy in patients undergoing cancer chemotherapy in community clinical settings. J Psychosoc Oncol. 2012;30(1):57-80. PubMed PMID: 22269076. **

194.     Agurs-Collins T, Rohrmann S, Sutcliffe C, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Platz EA. Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates. Cancer Causes Control. 2012;23(3):445-54. PMCID: PMC3333795. *

195.     Akinboye ES, Rosen MD, Denmeade SR, Kwabi-Addo B, Bakare O. Design, Synthesis, and Evaluation of pH-Dependent Hydrolyzable Emetine Analogues as Treatment for Prostate Cancer. J Med Chem. 2012;55(17):7450-9. PubMed  PMID: 22867001. *

196.     Ashktorab H, Entezari O, Nouraie M, Dowlati E, Frederick W, Woods A, Lee E,  Brim H, Smoot DT, Ghadyari F, Kamangar F, Razjouyan H. Helicobacter pylori  Protection Against Reflux Esophagitis. Dig Dis Sci. 2012;57(11):2924-8. PubMed PMID: 23010740.   

197.     Badurdeen DS, Umar NA, Begum R, Sanderson AK 2nd, Jack M, Mekasha G, Kwagyan J, Smoot DT, Laiyemo AO. Timing of procedure and compliance with outpatient endoscopy among an underserved population in an inner-city tertiary institution.  Ann Epidemiol. 2012;22(7):531-5. PMCID: PMC3371157. *

198.     Bhayani NH, Hyder O, Frederick W, Schulick RD, Wolgang CL, Hirose K, Edil B, Herman JM, Choti MA, Pawlik TM. Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012;152(2):218-26. (Not Supported Through NIH Funding). *

199.     Brandy Y, Ononiwu I, Adedeji D, Williams V, Mouamba C, Kanaan Y, Copeland RL Jr, Wright DA, Butcher RJ, Denmeade SR, Bakare O. Synthesis and cytotoxic activities of some 2-Arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines. Invest New Drugs. 2012;30(4):1709-14. NIHMS434394. *

200.     Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, Murphy G, Laiyemo AO, Wang Z, Cross AJ, Schatzkin A, Danta M, Srasuebkul P, Amin J, Law M, Breit SN, Lanza E. Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev. 2012;21(2):337-46. (Not Supported Through NIH Funding). **

201.     Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, Liu Y, Gu X. MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. PLoS One. 2012;7(1):e29750. PMCID: PMC3250477. **

202.     Chen A, Pollack CE. Who pays? Cost-sharing, tradeoffs, and the physicians' role in decision making. J Gen Intern Med. 2012;27(9):1097-9. PMCID: PMC3514999. **

203.     Dash C, Chung FL, Rohan JA, Greenspan E, Christopher PD, Makambi K, Hara Y, Newkirk K, Davidson B, Adams-Campbell LL. A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study. BMC Complement Altern Med. 2012;12:96. PMCID: PMC3414766. **

204.     DeKlotz TR, Chia SH, Lu W, Makambi KH, Aulisi E, Deeb Z. Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope. 2012;122(3):511-8. (Not Supported Through NIH Funding). **

205.     Doubeni CA, Laiyemo AO, Major JM, Schootman M, Lian M, Park Y, Graubard BI, Hollenbeck AR, Sinha R. Socioeconomic status and the risk of colorectal cancer: An analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2012;118(14):3636-44. PMCID: PMC3422782. **

206.     Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, Sinha R, Allison J. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst. 2012;104(18):1353-62. PMCID: PMC3529596. **

207.     Doubeni CA, Schootman M, Major JM, Stone RA, Laiyemo AO, Park Y, Lian M, Messer L, Graubard BI, Sinha R, Hollenbeck AR, Schatzkin A. Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health. 2012;102(4):680-8. PMCID: PMC3489366. **

208.     Higgins AY, Doubeni AR, Phillips KL, Laiyemo AO, Briesacher B, Tjia J, Doubeni CA. Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study. BMC Gastroenterol. 2012;12:23 PMCID: PMC3352176. **

209.     Hoffman HJ, LaVerda NL, Young HA, Levine PH, Alexander LM, Brem R, Caicedo L,   Eng-Wong J, Frederick W, Funderburk W, Huerta E, Swain S, Patierno SR. Patient  navigation significantly reduces delays in breast cancer diagnosis in the  District of Columbia. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1655-63.   NIHMS404752.   

210.     Huang WY, Su LJ, Hayes RB, Moore LE, Katki HA, Berndt SI, Weissfeld JL, Yegnasubramanian S, Purdue MP. Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2012;21(11):2014-21. PMCID: PMC3493855.   

211.     Hudson TS, Carlson BA, Hoeneroff MJ, Young HA, Sordillo L, Muller WJ, Hatfield DL, Green JE. Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis. 2012;33(6):1225-30. PMCID: PMC3514862. **

212.     Hudson TS, Perkins SN, Hursting SD, Young HA, Kim YS, Wang TC, Wang TT. Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment. Int J Oncol. 2012;40(4):1113-21. PubMed PMID: 22266918. **

213.     Jackson DS, Egbuonnu N, Umunakwe C, Fullum TM, Ford DH, Anders KB, McDonald-Pinkett S, Smoot DT, Laiyemo AO. Scheduled out-patient endoscopy and lack of compliance in a minority serving tertiary institution. Am J Med Sci. 2012;344(3):194-8. PMCID: PMC3314107. **

214.     Jaeschke H, Williams CD, McGill MR. Caveats of using acetaminophen  hepatotoxicity models for natural product testing. Toxicol Lett. 2012;215(1):40-1. (Not Supported Through NIH Funding).     

215.     Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK 2nd, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiol. 2012;36(4):395-9. PMCID: PMC3288883. **

216.     Llanos AA, Dumitrescu RG, Marian C, Makambi KH, Spear SL, Kallakury BV, Perry   DJ, Convit RJ, Platek ME, Millen AE, Adams-Campbell LL, Freudenheim JL, Shields  PG. Adipokines in plasma and breast tissues: associations with breast cancer risk  factors. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1745-55. (Not Supported Through NIH Funding).   

217.     Llanos AA, Makambi KH, Tucker CA, Shields PG, Adams-Campbell LL. Alcohol, anthropometrics, and breast cancer risk in African American women. Breast J. 2012;18(4):394-5. (Not Supported Through NIH Funding). **

218.     Llanos AA, Makambi KH, Tucker CA, Wallington SF, Shields PG, Adams-Campbell LL. Cholesterol, lipoproteins, and breast cancer risk in African American women.  Ethn Dis. 2012;22(3):281-7. (Not Supported Through NIH Funding). **

219.     Marriott LK, Cameron WE, Purnell JQ, Cetola S, Ito MK, Williams CD, Newcomb  KC, Randall JA, Messenger WB, Lipus AC, Shannon J. Let's Get Healthy! Health awareness through public participation in an education and research exhibit. Prog Community Health Partnersh. 2012;6(3):331-7. doi: 10.1353/cpr.2012.0041.  PubMed PMID: 22982846.   

220.     McGill MR, Williams CD, Xie Y, Ramachandran A, Jaeschke H.  Acetaminophen-induced liver injury in rats and mice: Comparison of protein  adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of  toxicity. Toxicol Appl Pharmacol. 2012;264(3):387-94. PMCID: PMC3478469.     

221.     Nelson WG, DeMarzo AM, Yegnasubramanian S. USP2a activation of MYC in prostate cancer. Cancer Discov. 2012;2(3):206-7. (Not Supported Through NIH Funding). **

222.     Pastore LM, Young SL, Baker VL, Karns LB, Williams CD, Silverman LM. Elevated   prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian  reserve. Reprod Sci. 2012;19(11):1226-31. doi: 10.1177/1933719112446074. Epub  2012 May 10. PubMed PMID: 22581803.     

223.     Pollack CE, Noronha G, Green GE, Bhavsar NA, Carter HB. Primary care providers' response to the US Preventive Services Task Force draft recommendations on screening for prostate cancer. Arch Intern Med. 2012;172(8):668-70. PMCID: PMC3359062. **

224.     Pollack CE, Platz EA, Bhavsar NA, Noronha G, Green GE, Chen S, Carter HB. Primary care providers' perspectives on discontinuing prostate cancer screening. Cancer. 2012;doi: 10.1002/cncr.27577. PMCID: PMC3427393. **

225.     Pollack CE, Weissman G, Bekelman J, Liao K, Armstrong K. Physician social networks and variation in prostate cancer treatment in three cities. Health Serv  Res. 2012;47(1 Pt 2):380-403. PMCID: PMC3258347. **

226.     Pollack CE, Weissman GE, Lemke KW, Hussey PS, Weiner JP. Patient Sharing Among Physicians and Costs of Care: A Network Analytic Approach to Care Coordination Using Claims Data. J Gen Intern Med. 2012 Jun 14. [Epub ahead of print] PMCID Journal in Process. **

227.     Pollack CE, Platz EA , Bhavsar NA, Noronha G, Green GE, Chen S, Carter HB.  Primary care providers' perspectives on discontinuing prostate cancer screening. Cancer. 2012;118(22):5518-24. PMCID: PMC3427393.     

228.     Pollack CE, Slaughter ME, Griffin BA, Dubowitz T, Bird CE. Neighborhood  socioeconomic status and coronary heart disease risk prediction in a nationally representative sample. Public Health. 2012;126(10):827-35. PMCID: PMC3488146.  

229.     Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.  N Engl J Med. 2012;366(25):2345-57. NIHMS396202. **

230.     Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc. 2012;75(3):612-20. PubMed PMID: 22341106. **

231.     Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala  N, Bekelman JE. Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):8-15. PMCID: PMC3366632. **

232.     Taylor TR, Huntley ED, Sween J, Makambi K, Mellman TA, Williams CD,  Carter-Nolan P, Frederick W. An Exploratory Analysis of Fear of Recurrence among  African-American Breast Cancer Survivors. Int J Behav Med. 2012;19(3):280-7.  (Not Supported Through NIH Funding). **

233.     Kanarek NF, Tsai HL, Metzger-Gaud S, Damron D, Guseynova A, Klamerus JF, Rudin CM. Geographic proximity and racial disparities in cancer clinical trial participation. J Natl Compr Canc Netw. 2010 Dec;8(12):1343-51. ****

234.  Kanarek NF, Kanarek MS, Olatoye D, Carducci MA. Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study. Trials. 2012 Dec 10;13(1):237. ****

235.     Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson  MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis. 2012;18(12):2277-87. NIHMS355959. *

236.     Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B. Relationship  between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One. 2012;7(5):e37928. PMCID:  PMC3365111. **

237.     Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst. 2012;104(4):280-9. PMCID: PMC3283538. **

238.     Wenzel J, Jones RA, Klimmek R, Krumm S, Darrell LP, Song D, Stearns V, Ford JG. Cancer support and resource needs among African American older adults. Clin J Oncol Nurs. 2012;16(4):372-7. (Not Supported Through NIH Funding). **

239.     Williams CD, Regnier M, Daniel TL. Elastic energy storage and radial forces in  the myofilament lattice depend on sarcomere length. PLoS Comput Biol. 2012;8(11):e1002770. PMCID: PMC3499250.     

240.     Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, Loffredo CA, Zheng YL. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One. 2012;7(6):e39011. PMCID: PMC3377597. **

241.     Zhou Y, Sridhar R, Shan L, Sha W, Gu X, Sukumar S. Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity. Cancer Invest. 2012;30(2):119-25. PMCID: PMC3305793. *

 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer